Company data sheet · McKesson
McKesson: leaders came and went.
- Industry
- Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- United States
- Ticker
- MCK (NYSE)
- Sources
- SEC filings (1995–2026), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
- Data as of
- November 1, 2026
- Leaders came and went. McKesson filed 33 leadership changes since 2016, more than 81% of large wholesalers (the median is 25). The day after each, its shares moved a median 0.0 points against its sector. The news was rarely news.
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2016 | $191 billion | $2.3 billion | |
| 2017 | $199 billion | $5.1 billion | |
| 2018 | $208 billion | $0.1 billion | |
| 2019 | $214 billion | $0 billion | |
| 2020 | $231 billion | $0.9 billion | |
| 2021 | $238 billion | −$4.5 billion | |
| 2022 | $264 billion | $1.1 billion | |
| 2023 | $277 billion | $3.6 billion | |
| 2024 | $309 billion | $3 billion | |
| 2025 | $359 billion | $3.3 billion | |
| 2026 | $403 billion | $4.8 billion |
As reported in its annual filings. Losses in red.
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Market reaction to disclosed decisions: 53 decision filings since 2016, each linked to the SEC, with the share return against its sector and the US market the next day and the next year (36 with market data).
- Economic context: 7 measures for the United States, every year since 2016, from the official sources.
- Peer comparison: against 31 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.